3,8-Dialkylxanthines

Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen bonded directly to ring carbon of the purine ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544267, C07D47306, A61K 3152

Patent

active

045461821

ABSTRACT:
The invention refers to compounds having activity against chronic obstructive airway disease or cardiovascular disease, characterized by the formula ##STR1## wherein R.sup.1 is ethyl, n-propyl, n-butyl, isobutyl, n-pentyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexylmethyl, and R.sup.2 is methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert. butyl, or cyclobutyl provided that R.sup.1 is ethyl when R.sup.2 is methyl, or a physiologically acceptable salt thereof. The invention also refers to processes for the preparation of these compounds, a pharmaceutical preparation containing one of the compounds and a method for the treatment of chronic obstructive airway disease and cardiovascular disease.

REFERENCES:
patent: 4089959 (1978-05-01), Diamond
patent: 4233303 (1980-11-01), Bergstrand et al.
patent: 4325956 (1982-04-01), Kjellin et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3,8-Dialkylxanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,8-Dialkylxanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,8-Dialkylxanthines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2220964

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.